Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
764 USD | +0.83% | -1.77% | +31.06% |
05-14 | Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs | RE |
05-14 | Argus Adjusts Price Target on Eli Lilly to $840 From $770 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B | |
-1.42% | 161B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- BofA Securities Raises Price Target on Eli Lilly to $800 From $750, Maintains Buy Rating